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Available online 7 March 2012Abstract This study reports an effect of taurine (1–10 mM) increasing markedly (120%) the number of neural precursor cells
(NPCs) from adult mouse subventricular zone, cultured as neurospheres. This effect is one of the highest reported for adult
neural precursor cells. Taurine-containing cultures showed 73–120% more cells than controls, after 24 and 96 h in culture,
respectively. Taurine effect is due to enhanced proliferation as assessed by BrdU incorporation assays. In taurine cultures
BrdU incorporation was markedly higher than controls from 1.5 to 48 h, with the maximal difference found at 1.5 h. This effect
of taurine reproduced at every passage with the same window time. Taurine effects are not mimicked by glycine, alanine or
GABA. Clonal efficiency values of 3.6% for taurine cultures and 1.3% for control cultures suggest a taurine influence on both,
progenitor and stem cells. Upon differentiation, the proportion of neurons in control and taurine cultures was 3.1% (±0.5)
and 10.2% (±0.8), respectively. These results are relevant for taurine implication in brain development as well as in adult
neurogenesis. Possible mechanisms underlying taurine effects on cell proliferation are discussed.
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factor 2; BrdU, 5-bromo-2′-deoxyuridine; TauT, taurine transporter.
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Taurine is a sulfur amino acid, present in large amounts inmost
cell types and tissues as a free amino acid. It is not a protein
amino acid and participates in only few metabolic reactions
(Huxtable, 1992). Taurine has a function as osmoregulator
(Pasantes-Morales, 2007) and exhibits a protective effect in a
variety of detrimental situations, often acting as antioxidant
(Schaffer et al., 2009). Early studies on brain taurine point to
its involvement in brain development. Taurine levels in the im-
mature brain are 3–4-fold higher than in the adult brain, a
decrease consistently observed regardless of the species
variations in brain taurine content (Agrawal et al., 1968;
Figure 1 Effect of taurine on the number of NPCs grown as
neurospheres. Neurospheres generated in EGF/FGF2 plus or
minus taurine, were mechanically disaggregated and the cells
were directly counted. A. Cells from primary neurospheres
(P1) or from secondary neurospheres at different culture pas-
sages (P2–P4). At each passage (P) the number of NPCs was
counted. Bars represent the percentage increase in NPCs
25Taurine and neural stem/progenitor cellsSturman andGaull, 1975; Miller et al., 2000). Taurine deficien-
cy disturbs development in cats (Sturman, 1993) leading to a
delay in cell division and migration in cerebellum and visual
cortex (Sturman et al., 1985; Palackal et al., 1986). Similarly,
taurine deprivation in newborn monkeys results in abnormali-
ties in the visual cortex characterized by delayed migration
of neurons and poor differentiation of pyramidal cells
(Neuringer et al., 1990). Furthermore, studies in vitro in cul-
tures of dissociated cerebellum showed that cell taurine de-
pletion significantly reduces cell migration (Maar et al.,
1995). It seems therefore that a deficiency of taurine disturbs
the developmental precise program of cellular proliferation,
migration and differentiation. In further support to an involve-
ment of taurine in brain development, a recent study reports
that the detrimental influence of gestational protein restric-
tion on fetal brain is prevented by supplement of taurine dur-
ing pregnancy (Liu et al., 2011).
The mechanism(s) of this taurine requirement for brain de-
velopment are poorly understood. The influence of taurine
may be exerted on cell division, migration or/and differentia-
tion. These possibilities can be examined in a preparation of
neural precursor cells (NPCs) collectively including neural pro-
genitor and stem cells, which are characteristically prolifera-
tive and self renewing, and maintain the ability to
differentiate into neural cell lineages (Reynolds et al., 1992;
Rietze and Reynolds, 2006). NPCs actively proliferate in cul-
tures as floating spherical clusters called neurospheres. This
is a widely used technique to characterize a variety of NPCs
features. In the proper conditions, i.e. free-serum media sup-
plemented with specific growth factors, NPC cultures can be
expanded through several passages. If then switched to
serum-containing media, NPCs differentiate into astrocytes,
neurons and oligodendrocytes, which are formed in different
proportion, being astrocytes the most abundant cell type
formed (Ahmed, 2009). A previous study from our laboratory
described an effect of taurine increasing proliferation of
NPCs generated from embryonic mouse mesencephalon
(Hernández-Benítez et al., 2010a) but there is no information
about taurine effects in NPCs from the adult brain.
Interest in studies about adult NPCs is raised by the possi-
bility of increasing and manipulating neurogenesis in the
adult brain. Neurogenesis persists in some regions of the
adult brain derived from NPCs located at the SVZ of the lat-
eral ventricules (Ming and Song, 2011), and it is enhanced by
brain injuring conditions such as ischemic stroke, seizures or
in neurodegenerative diseases (Arvidsson et al., 2002;
Nakatomi et al., 2002; Parent, 2007; Vandenbosch et al.,
2011). NPCs may then be a source of neuronal replacement
during brain repair. It is therefore of interest to investigate
whether taurine has an influence on proliferation or/and dif-
ferentiation of NPCs obtained from the adult brain. The pre-
sent study on NPCs obtained from the SVZ of adult mice
brain, examined whether taurine affects cell viability and
proliferation and evaluated its effect on the proportion of
astrocytes and neurons generated after differentiation.grown in the presence of 10 mM taurine (black bars) over the
control condition (empty bars). The number of cells in empty
bars was set at 100% to homologate differences between prima-
ry and secondary passages. B. Increase with time of the number
of NPCs from neurospheres grown in the control medium (□) or
in the presence of 10 mM taurine (■). Values are means±SE,
n≥5 experiments, significantly different at *Pb0.05.Results
Neural precursor cells (NPCs) of the SVZ of mice adult brain,
cultured as neurospheres were used in this study. NPCs fromadult tissue are currently defined by self-renewal, positive
reaction to nestin and multipotent differentiation. We
found that i) neurospheres are formed from the dissociated
SVZ and expanded through several passages, ii) cells forming
neurospheres from passages 1 to 6 ranged 90.4–95.5% posi-
tive to nestin, 0.92–2.2% positive to GFAP and 1.2 to 2.3%
positive to β-III-tubulin, and iii) under the appropriate condi-
tions, NPCs differentiate into neurons (β-III-tubulin-positive
cells) , and astrocytes (GFAP-positive cells) with a marked re-
duction (up to 2.9%) of nestin-positive cells (Supplementary
Figs. 1A–C). It can be then reasonably concluded that our
cultures contain essentially NPCs organized as neurospheres.
As shown by the range of variation in the quantitative compo-
sition of cells, no significant difference was found through the
several passages, 1–6.
26 R. Hernández-Benítez et al.The effect of taurine on NPCs was examined in primary
neurosphere cultures as well as on the secondary neuro-
spheres formed after successive culture passages, up to
4–6 passages. Primary neurospheres originate directly from
the excised SVZ, and cultured in a conditioned medium with-
out FBS. Growth and proliferation of NPCs forming neuro-
spheres are sustained by the growth factors EGF and FGF2.
No neuropheres were formed in cultures with taurine but
without growth factors.
Addition of taurine to cultures markedly increased the
number of NPCs. All secondary cultures start with a similar
number of cells (about 200×103), which is referred to as
the initial cell number. After 96 h, taurine cultures contained
about 120% more cells than control cultures. This effect of
taurine was consistently observed in primary cultures as
well as in secondary cultures at all passages (Fig. 1A). The in-
crease with time (1–4 days) of NPC number in cultures in the
presence or absence of taurine is shown in Fig. 1B. After 24 h
taurine cultures have significantly more cells (73%) thanFigure 2 Viability and BrdU incorporation of NPCs formed over the
course of cellular BrdU incorporation, after a 1.5 h pulse (see Mater
cells over total cells counted in control cultures (□) or in taurine con
the percentage of BrdU+ cells found after 96 h in culture, immediate
termined by the Trypan blue exclusion assay as described in Materia
means±SE of 4–12 experiment. Significantly different from their recontrols. This difference further increased with time, and
at 48, 72 and 96 h, taurine cultures have, respectively, 85%,
116% and 120% more cells than controls (Fig. 1B).
The effect of taurine increasing NPC number may result
from a protective action improving cell viability or/and
from an increase in proliferation. This was examined by
measuring viability by the Trypan blue exclusion and MTT as-
says, and proliferation by BrdU incorporation. Fig. 2A shows
the time course of BrdU incorporation, in cells cultured with
or without taurine. BrdU incorporation was monitored at
short times in culture, 1.5, 3, 6 and 12 h, and thereafter
every 24 h up to 96 h (Fig. 2A). In control cultures, the per-
centage of BrdU+ cells found immediately after neurosphere
disaggregation in the previous passage was 14% (initial point
of the curve) and this number remained essentially
unchanged during the first 12 h in the new culture. During
the next hours (24–48 h) the number of BrdU+ cells in-
creased up to 24% and thereafter a decline was observed
(Fig. 2A). The BrdU incorporation pattern in the presencetime in culture in the presence or absence of taurine. A. Time-
ials and methods). Results are expressed as percentage of BrdU+
taining cultures (■). The initial point in the curve corresponds to
ly after neurosphere disaggregation (△, ▲). B. Cell viability de-
ls and methods. C. Cell viability assayed by MTT. Bars represent
spective controls at *Pb0.05.
27Taurine and neural stem/progenitor cellsof taurine was markedly different than in controls. The per-
centage of BrdU in cells from dissociated neurospheres was
about 12%, but once seeded for a new culture, a striking
and fast increase in BrdU incorporation occurred, so that as
early as 1.5 h of culture the number of BrdU+ cells has dou-
bled attaining 26% of NPCs. At this time a BrdU incorporation
peak was observed (Fig. 2A). BrdU incorporation rate slightly
increased in the following days up to 48 h, and declined
thereafter. Upon neurosphere disaggregation to start a new
cycle of expansion, the effect of taurine increasing BrdU in-
corporation occurs again, with the same window time, and
this sequence of events reproduces at every passage. Com-
paring the BrdU incorporation curve in control and taurine
cultures, it is evident that taurine was markedly increasing
the number of NPCs in DNA synthesis phase during the first
hours after seeding (Fig. 2A). In contrast, taurine did not af-
fect cell viability, examined by Trypan blue exclusion and
MTT assays. No difference was found at any time between
1.5 and 96 h between taurine and control cultures
(Figs. 2B, C). Apoptotic death estimated by TUNEL was
found to be lower than 3%, in cultures either in the presence
or absence of taurine (results not shown).Figure 3 Concentration-dependent effect of taurine and other am
trol condition (empty bars), in taurine condition (black bars) or in th
concentrations (in mM). After 5 days in culture, neurospheres
A. Concentration-dependent effect of taurine. B. Effect of the a
10 mM) on NPC number. C. Concentration-dependent effect of GAB
Significantly different from control at *Pb0.01, significantly differeTaurine effect increasing NPC number was examined at
taurine concentrations ranging 0.1 to 30 mM. Maximal effect
was found at 10 mM, but some increase was observed al-
ready at 0.5 mM although it was significant only from 1 mM
(Fig. 3A). Other amino acids such as GABA, glycine or ala-
nine, at the same concentration, did not modify NPC num-
ber. Only the amino acids structurally similar to taurine,
hypotaurine and β-alanine, exhibited some effect increasing
NPC number although it is clearly lower than that of taurine
(Fig. 3B). In embryonic NPCs, GABA shows a proliferative ef-
fect at low doses (Nakamichi et al., 2009). In adult NPCs,
GABA (1–10 mM) induced a slight decrease in cell number
(Fig. 3C).
NPCs is used as a generic term including stem cell and
progenitor cells. To investigate whether the effect of tau-
rine above described occurs on the neurosphere stem cells
as well as on progenitor cells, NPCs were seeded at low-
density on a 96 wells plate (25 cells per well; 0.25 cells/μL)
and the total number of neurospheres generated after
7 days was counted. Under these conditions, control cultures
generated 31 (±4) neurospheres per plate while in the pres-
ence of taurine 86 (±14) neurospheres per plate wereino acids on NPC number. Neurospheres were generated in con-
e presence of other amino acids (spotted bars), at the indicated
were disaggregated and the number of NPCs was counted.
mino acids: hypotaurine, β-alanine, glycine and L-alanine (at
A on NPC number. All results are means±SE, n≥4 experiments.
nt from taurine bar ** Pb0.05 and ● Pb0.01.
28 R. Hernández-Benítez et al.formed, an increase of 177% (Fig. 4). The clonal efficiency in
cultures with or without taurine was calculated and results
showed a markedly higher efficiency in the presence of tau-
rine than in controls (Fig. 4).
Taurine concentration in the SVZ of the lateral ventricles
from which NPCs were obtained was 14.5 μmol/g protein,
but the taurine content in cells forming neurospheres in the
absence of taurine is of only 2 μmol/g protein. Upon taurine
addition to the culture medium, this concentration strikingly
increased up to 240 μmol/g protein (Fig. 5B), a level higher
than that of other adult brain regions (Fig. 5A), and compara-
ble to that found in fetal brain. This ability to concentrate
taurine indicates the presence of an efficient mechanism
for taurine uptake into the cell. In most cell types, taurine
accumulates by the operation of a well characterized
energy-dependent transporter TauT. The molecular expres-
sion of TauT in NPCs was detected by immunocytochemistry.
As shown in Fig. 6A TauT is expressed in essentially all
(92.8±2.6%) NPCs. The functional expression of TauT was
also examined. Fig. 6B shows taurine uptake by NPCs incu-
bated with increasing concentrations of unlabelled taurine
in a range of 1 to 200 μM and 0.8 μCi/mL of 3H-taurine.
Total taurine uptake include a nonsaturable and a satura-
ble component. The non-saturable component was identi-
fied by measuring 3H-taurine uptake when cells were
incubated in a Na+-free medium (NaCl replaced by KNO3).
Subtraction of this non-saturable component from total up-
take revealed the saturable component. The kinetic constant
values of the saturable taurine uptake calculated from the
Lineweaver–Burk equation were a Vmax of 493 pmol/mg
protein/min and a Km of 41.7 μM (Fig. 6B).
Differentiation of NPCs was induced by replacing the cul-
ture medium by a medium without growth factors and con-
taining 1% FBS. Under this condition, NPCs generated
astrocytes and neurons. Astrocyte was the most abundant
cell type, present in a proportion of 89.6% (±1.3%). The pres-
ence of taurine in the differentiation medium only marginal-
ly decreased the percentage of astrocytes (85.6±1.0%). The
proportion of neurons, identified by β-III-tubulin, was onlyFigure 4 Clonal efficiency in taurine and control cultures. Sec-
ondary neurospheres were gently dissociated and seeded at low
density (25 cells/well) on 96-well dishes, in the presence or absence
of taurine. After seven days in culture, the number of formed neuro-
spheres was counted and the clonal efficiency was calculated. Bars
(±SE) represent the mean of neurospheres/plate in each condition.
Significantly different *Pb0.05.3.1% (±0.5%). In the presence of taurine the number of
β-III-tubulin-positive neurons increased up to 10.2% (±0.8%)
(Figs. 7A, B, C). Neurons positive to the mature neuron
marker MAP2 in control cultures were 1.8% (±0.4%), and in-
creased to 5.1% (±0.5%) in taurine cultures (Supplementary
Fig. 2). These results correspond to cells growing in 1% FBS
medium during one week. The proportion of β-III-tubulin
and of MAP2 positive neurons decreased at longer times in
culture of 2–3 weeks, and the effect of taurine also propor-
tionally decreased (Supplementary Fig. 3). Other differenti-
ation media were tested in this study, as follows: 1. B27
replacing FBS, 2. ascorbic acid replacing FBS, 3. medium
without FBS, 4. neurobasal medium plus B27. In the ascorbic
acid medium and medium without factors, only a few num-
ber of cells survived. In the B27 medium the number of
cells in the culture, including neurons decreased by 50%. In
the neurobasal/B27 medium mainly neurons survived asFigure 5 Taurine concentration of adult mouse brain tissues
and of NPCs. Taurine levels were measured by HPLC as de-
scribed in Materials and methods. A. Taurine content of adult
neural tissues. Fresh tissue samples were isolated from cortex,
olfactory bulbs and from the lateral ventricles and processed
for HPLC. B. Neurosphere taurine content. Neurospheres gener-
ated in the EGF/FGF condition plus or minus taurine were col-
lected and treated for HPLC measurements. Bars represent net
taurine concentration, i.e. after subtraction of taurine values
found in cells exposed to 10 mM taurine and immediately
washed and processed for quantification. Data are means±SE
of 3–4 experiments.
Figure 6 Molecular and functional expression of TauT in NPCs. A. TauT reactivity was detected by immunocytochemistry in NPCs
from disaggregated neurospheres, using a primary anti-TauT antibody, followed by the secondary antibody Alexa fluor 568 (red). Nu-
clei were counterstained with Hoechst (blue). Reactivity was visualized by epifluorescence microscopy. The photomicrographs are
from a representative assay. B. Kinetic analysis of 3H-taurine uptake by NPCs. Cells were incubated during 30 min with 3H-taurine
(29 nM), and unlabeled taurine over a concentration range of 1–200 μM. The lines represent the total taurine uptake (x), the uptake
measured in a Na+-free medium (NaCl replaced by KNO3) (non-saturable component) (■) and the uptake resulting from subtracting
the Na+/Cl− independent uptake (saturable component) (▲). Uptake rates were calculated from the amount of radioactivity in the
cells after the uptake period and the unlabeled taurine in the incubation media. C. Lineweaver–Burk plot of the saturable component
and values of Vmax and Km calculated using the Lineweaver–Burk equation. Results are means±SE of 13 experiments.
29Taurine and neural stem/progenitor cellsexpected, being this medium directed to neuronal growth.
However, the number of neurons in this medium decreased
by 45% as compared to the FBS medium. Taurine significantly
increased the proportion of neurons formed in neurobasal/
B27 and in medium without FBS, but to a lower extent than
in the 1% FBS medium.Discussion
The present study reports an effect of taurine markedly in-
creasing the number of NPCs obtained from the SVZ of
adult mouse brain, and grown in culture as neurospheres.
The taurine-induced increase in NPC number, of over 120%,
is one of the highest reported for any other molecule or con-
dition in NPCs from adult brain, including melatonin, dopa-
mine or neuropeptides (O'Keeffe et al., 2009; Sotthibundhu
et al., 2010; Thiriet et al., 2011). We recently reported an
effect of taurine increasing the number of embryonic NPCs
(Hernández-Benítez et al., 2010a), but the effect now ob-
served in NPCs derived from the SVZ is over 5-fold higher
than that in embryonic cells. The reason for this difference
is so far unclear, and could be related to the fact that em-
bryonic cells are growing in an environment rich in taurine,
while in the adult brain, taurine levels are much lower.Taurine concentrations of 1–10 mM, required for its action
in increasing NPC number are within the range of taurine
content found in most cells types, including brain cells
(Huxtable, 1992; Wójcik et al., 2010). Taurine content of
NPCs cultured in a taurine-free medium is very low, but
upon addition of taurine there is a fast accumulation, in-
creasing the cell taurine content up to attain the fetal
brain levels. This is likely occurring via the taurine specific
carrier TauT. We found this transporter expressed and func-
tionally active in NPCs derived from the adult brain. TauT is
present in essentially all animal cells, where it is in charge of
taurine uptake from plasma, and has a critical role in main-
taining the intracellular taurine levels characteristic of
each cellular type. The kinetic constant values for TauT
found in adult NPCs cells are within the range found in
most cell types, including embryonic NPCs (Hernández-
Benítez et al., 2010b).
The increase in the number of NPCs observed in cultures
containing taurine is not due to an effect enhancing cell sur-
vival but rather results from an action on cell proliferation,
as evidenced by the BrdU incorporation assay. Taurine
seems not to be a mitogen per se, since in the absence of
the growth factors, no neurospheres are formed in the tau-
rine containing medium. It is only when the proliferative ac-
tivity has initiated that taurine stimulates proliferation.
Figure 7 Taurine effect on proportion of cell lineages derived from NPCs. Neurospheres were dissociated and cultured in media
containing 1% FBS in the absence of growth factors. After 7 days, cultures were immunostained for the astrocyte marker GFAP
(green) or neuron marker β-III-tubulin (red). Nuclei were counterstained with Hoescht (blue). A. Distribution of differentiated cells
in control o taurine condition. B. Representative photomicrographs imaged at 20×. C. Taurine effect on the proportion of astrocyte
(left panel) or neurons (right panel) differentiated from NPCs. Bars represent means±SE of ≥12 experiments. Significantly different
*Pb0.05.
30 R. Hernández-Benítez et al.Assays of BrdU incorporation as used in this study showed a
progressive increase in the number of cells with DNA replica-
tive activity up to 48 h in culture, when the activity de-
clines, suggesting the transit to the phases of the cell
cycle. Taurine markedly influenced the magnitude and
time course of DNA synthesis in NPCs. In the presence of tau-
rine, substantially more NPCs exhibit DNA replicative activi-
ty at a significant shorter time than in controls and this
effect results in the notable increase in cell number found
in taurine cultures already after 24 h of a new passage.
After this time the difference in BrdU incorporation between
taurine and control cultures decreases, and no difference is
observed anymore at 72 h. but the initial difference in the
number of formed cells persists through all culture days, so
that taurine cultures contain more cells than controls, at
all times.
We aimed here to elucidate whether the effect of taurine
increasing proliferation occurs on stem cells as well as onneural progenitor cells. Neurospheres are formed by aggre-
gates of neural progenitor cells around one or several stem
cells, but may also be formed by clusters of progenitor
cells only (Rietze and Reynolds, 2006). The protocol of low-
cell density was used in the present study to test whether
taurine effect enhancing proliferation occurs in stem cells.
A low plating density of 5–50 cells/μL has been considered
as a clonal condition, .i.e. a condition in which each one of
the formed neurospheres is presumably generated from a
stem cell (Campos, 2004). The cell density used in the pre-
sent study of 25 cells/well (0.25 cells/μL in 100 μL) is
among the lowest reported for NSCs, and the clonal efficien-
cy obtained of 1.3%, is not far from the 2% calculated for the
single-cell clonal efficiency (Engstrom et al., 2002). Our re-
sults show that taurine markedly enhances the number of
neurospheres formed, with a clonal efficiency of 3.6%. Al-
though this approach is not providing rigorous evidence of
a clonal condition, the low dilution of the assay minimizes
31Taurine and neural stem/progenitor cellsthe possibility of neural progenitor coalescence, and in-
creases the possibility of neurosphere formation due to the
presence of stem cells. From these considerations there is
a reasonable possibility that the effect of taurine is exerted
on both, stem cells and neural progenitor cells.
The mechanism(s) of the stimulatory effect of taurine on
cell proliferation here described are still unknown
(Pasantes-Morales and Hernández-Benítez, 2010). A possibil-
ity, based on the time course of DNA replicative activity ob-
served in the presence or absence of taurine, is of that the
mechanical disaggregation of neurospheres creates adverse
conditions for DNA synthesis, and that this is prevented by
taurine. Taurine cell protective activity is well documented
although its mechanism is still unclear. Activity as antioxi-
dant, a modulator of calcium homeostasis, or a general ef-
fect on membrane stability, are suggested possibilities
(Schaffer et al., 2009). Taurine may influence proliferation
via an effect on the redox state of the cells, which is
known to regulate DNA replication and cell proliferation in
various cell types, including NPCs (Kim and Wong, 2009).
The antioxidant properties of taurine, reported in a variety
of cells and tissues (Schaffer et al., 2009), by preventing
redox imbalance in NPCs, may preserve favorable conditions
for proliferation (Sharma et al., 2008; Kim and Wong, 2009).
However, unpublished studies from our laboratory did not
find any effect of general antioxidants increasing prolifera-
tion of NPCs as taurine did, a result arguing against an anti-
oxidant action of taurine as the mechanism underlying its
effect on NPCs proliferation.
Another possibility is related to a possible interaction of
taurine with the GABAA receptor.
High concentrations of taurine as those showing its prolif-
erative effect may act as agonists of the GABAA receptor
(Albrecht and Schousboe, 2005) and through this mechanism
could regulate proliferation. This is also an unlikely possibil-
ity since even when GABA stimulates proliferation in certain
conditions in embryonic NPCs (Fukui et al., 2008), in adult
cells GABA decreases proliferation, as confirmed in the pre-
sent study, an action opposite to that of taurine. Taurine-
induced cell swelling may possibly be related to its prolifer-
ation regulatory effect. There is evidence showing that an
increase in cell volume can regulate proliferation (Stutzin
and Hoffmann, 2006). The large amounts of taurine accumu-
lated by NPCs may lead to cell swelling and via this mecha-
nism, affecting proliferation. However, other amino acids
such as glycine, alanine and GABA also tested at high con-
centrations may as well accumulate into the cells and induce
similar swelling (Andäng et al., 2008), and nevertheless, did
not exhibit the same effect as taurine in cell proliferation.
Alternately, taurine may be affecting the rate of cell mi-
gration and through this mechanism accelerate cell prolifer-
ation. By increasing cell adhesion or/and accelerating
migration on the plate, cells get close faster and this proxim-
ity may then generate a propitious condition for prolifera-
tion, as has been suggested (Mori et al., 2006). In any
event, the time course of the taurine effects on BrdU incor-
poration suggests its influence on mechanisms related to the
progress of the DNA replication phase of the proliferation
cell cycle. Taurine might exert this action by directly
influencing the chromatin structure, via electrostatic or hy-
drophobic interactions with the DNA. There is evidence
showing the presence of high taurine levels in nuclei ofother cell types (Lobo et al., 2000a,b). Thus, taurine could
favor a more propitious chromatin configuration for DNA syn-
thesis, and via this action regulate NPC proliferation (Buche
et al., 1989). This possibility is now under investigation in
our laboratory.
In addition to its effect on cell proliferation, taurine in-
duced a significant increase in the proportion of neurons
formed during the NPC differentiation process. The mecha-
nism of this action is so far unknown.
The present results in NPCs from the present study may
be relevant for the taurine role in brain development.
Since the early studies of Sturman et al. (1985), it is known
that taurine deficiency impairs brain development, disturb-
ing the sequence of cell mitosis, migration and organization.
After three decades, the reason for this taurine requirement
for optimal brain development remains obscure. An in vitro
system as that used in the present study offers a useful ex-
perimental model to clarify the role of taurine on brain
developing cells. Taurine may also be required for neurogen-
esis in the adult brain. One of the few regions where neuro-
genesis persists in the adult brain is the SVZ of the lateral
ventricules which provide new neurons to the olfactory
bulb during adulthood. Cells from the SVZ proliferate and
migrate via the rostral migratory stream to the olfactory
bulb where they differentiate into neurons, mostly into
granule cells, which integrate into the functional circuitry
of the bulb (Lledo et al., 2008). Of relevance for taurine im-
plication in neurogenesis, the olfactory bulb contains the
highest taurine levels in the adult brain, and in contrast to
most brain regions, there is no taurine decline during brain
maturation (Miranda-Contreras et al., 2000). The high levels
of taurine in the olfactory bulb may then respond to a re-
quirement for the optimal proliferation, migration and dif-
ferentiation of the NPCs in the adult brain.
Altogether, results of the present study point to the NPCs
as an interesting system to examine in detail the mecha-
nisms by which taurine participates in brain development
and of its presumed requirement for neurogenesis in the
adult brain. In another context, they provide a rationale
for considering the use of taurine as a factor to enrich niches
of neurogenesis when the cell replacement therapy is the
strategy of choice for brain injuries and diseases.Materials and methods
Materials
DMEM/F12 (Dulbecco's Modified Eagle Medium) with L-
glutamine and 15 mM HEPES, Pen Strep (penicillin strep-
tomycin), fetal bovine serum (FBS), epidermal growth factor
(EGF), fibroblast growth factor 2 (FGF2), glutamax 100×, goat
serum (GS), Neurobasal medium, B27 medium, antibodies
Alexa fluor 488 (chicken anti-rat) and Alexa fluor 568 (goat
anti-rabbit) were from GIBCO, Invitrogen. Anti-β-III-tubulin,
progesterone, sodium selenite, putresine (1-4-diaminobu-
tane-dihydrocloride), human transferrin, human insulin, 5-
bromo-2′-deoxyuridine (BrdU), bisbenzimide H 33258 (Hoechst),
o-phthaldialdehyde (OPA), D-(+)-glucose, Triton 100×, brilliant
blueG, MTT [3–84,5-Dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide], dimethyl sulfoxide (DMSO), phosphate
buffered saline (PBS), γ-aminobutyric acid (GABA), β-alanine,
32 R. Hernández-Benítez et al.L-alanine, glycine, hypotaurine, ascorbic acid and poly-L-lysine
hydrobromide, were from Sigma Aldrich. Monoclonal rat
anti-bromodeoxyuridine antibody (Rat Mab anti-BrdU), rat
anti-GFAP, polyclonal mouse nestin tail and MAP2, were
from Accurate Chemical & Scientific Corporation, ZYMED
Invitrogen, COVANCE and Santa Cruz Biotechnology, respec-
tively. DeadEndTM Fluorometric TUNEL System was from
Promega. Bovine serum albumin (BSA) was from Calbio-
chem. Ethanol and methanol were from Reactivos Química
MEYER. Paraformaldehyde (CH2O)n, potassium acetate, and
hydrochloric acid (HCl) were from J.T. Baker and taurine
(ultraN99.5%) was from in BioChemika Fluka.
Cultures
Animals used in this study were cared for in accordance with
the Norma Oficial Mexicana NOM-062-ZOO-1999. SVZ from
CD1 adult mouse (6–8 weeks) was dissected and transferred
into ice-cold culture medium containing: DMEM/F12, 1% glu-
tamax 100×, 25 μg/mL insulin, 100 μg/mL transferrin, 20 nM
progesterone, 60 μM putresine, 30 nM sodium selenite, 50 U/
mL penicillin and 50 μg/mL streptomycin. The tissue was
triturated with a micropipette and the supernatant was col-
lected and centrifuged at 1000 rpm/5 min. The pellet was
resuspended with culture medium, and cells were seeded
in the presence of EGF and FGF2 (20 ng/mL each) in sterile
6-well plates (4×104 cells/well) or plus 10 mM taurine. Cul-
tures were incubated at 37 °C in humidified 5% CO2/95% air
atmosphere. EGF (20 ng/mL) was added to cultures every
48 h. After 12 days, primary neurospheres were collected
by centrifugation (1000 rpm/5 min), disaggregated and re-
seeded at 2×105 cells/well in sterile 6-well plates. Second-
ary neurospheres were obtained after 4 days. Unless other-
wise indicated, all the experiments were carried out with
secondary cultures between 2 and 6 passages. For studies
on taurine dose/dependent effect or to test other amino
acids, cells were seeded in EGF/FGF2 medium at 5×104
cells/well in 24-well plates, and grown in media containing
the indicated concentration of amino acids. The number of
cells in cultures was measured by direct counting after
6 days on a Neubauer chamber. In all cultures, viability was
determined by Trypan blue exclusion assay.
For lineage analysis of undifferentiated NPCs, the neuro-
spheres were disaggregated, cells plated (100×103) on pre-
treated poly-L-lysine 96-well microplates. Cells were incubat-
ed at 37 °C in humidified 5% CO2/95% air atmosphere during
2 h, and then fixed and processed by immunocytochemistry.
For NPC differentiation the neurospheres were disaggre-
gated, washed and cells (50×103) were plated on pre-treated
poly-L-lysine cover slips, and cultured in a medium without
growth factors, containing 1% FBS in the presence or absence
of 10 mM taurine. Cultures were incubated at 37 °C in humidi-
fied 5% CO2/95% air atmosphere during 7, 14 or 21 days and
then fixed and processed for immunocytochemistry.
MTT assay
Neurospheres were mechanically dissociated and cells were
seeded on poly-L-lysine-treated in 48-well plates (2×105
cells/well) with EGF/FGF2 medium in the presence or
absence of 10 mM taurine. After the indicated cultureconditions, MTT reconstituted in PBS (1 mg/mL) was added
to obtain 0.1 mg/mL final concentration, and cells incubat-
ed during 60 min at 37 °C. After incubation, the formazan
reaction products were dissolved with DMSO, wells stirred
for 5 min on a plate shaker and the optical density measured
in an UV-2100 Spectrophotometer (Cole Parmer) at 570 nm.
TUNEL assay
The TUNEL assay was carried out using the DeadEndTM Fluo-
rometric TUNEL System. After the indicated treatments cells
were fixed with 4% paraformaldehyde, permeabilized with
0.2% Triton 100x during 5 min and incubated in darkness
with the TUNEL reaction mixture (equilibration buffer,
terminal deoxynucleotidyl transferase, and nucleotide mix)
for 60 min at 37 °C. Nuclei were counterstained with Hoechst.
Cells were observed in an epifluorescence microscope Olympus
IX71 andmicrophotographs obtained from the QCapture Pro 6.0
software. The percentage of TUNEL-positive cells was calculat-
ed over the total of cells counted.
Low density assay
Neurospheres were mechanically disaggregated to obtain a
single cell suspension. The cells were seeded on 96-well
microplates (25 cells/well) containing EGF/FGF2 medium
(100 μL/well) in the presence or absence of 10 mM taurine.
Cultures were incubated at 37 °C in humidified 5% CO2/95%
air atmosphere, and after 7 days the formed neurospheres
were counted.
BrdU incorporation and immunocytochemical
detection
For assays of BrdU incorporation, a 1.5 h-pulse of 10 μM BrdU
was applied to cultures, before the indicated time. Cells
were collected, washed and resuspended with culture medi-
um, and plated on poly-L-lysine-treated 96-well micro-
plates. Ninety minutes after plating, cells were fixed in 4%
cold paraformaldehyde for 15 min, washed (3-times 5 min
each) with PBS plus 0.1% BSA, incubated 15 min with pre-
heated PBS plus 2N HCl solution (37 °C), washed and per-
meabilized/blocked with a solution containing PBS+0.1%
BSA+10% GS+0.3% Triton 100 ×, during 1 h, at room temper-
ature. Cells were incubated overnight at 4 °C with [1:100]
anti-BrdU antibody followed by 1 h incubation with [1:200]
Alexa fluor 488 to visualize the signal. Nuclei were counter-
stained with 2 μg/mL Hoechst diluted in PBS. Microphoto-
graphs were obtained by direct epifluorescence microscope
Olympus IX71 using the QCapture Pro 6.0 software and data
analyzed with Adobe Image 7.0 software. The percentage
of BrdU-positive cells was calculated over the total of cells
counted.
Immunocytochemistry
For cell lineage analysis cultured cells were fixed in 4% cold
paraformaldehyde (15 min), washed (3-times, 5 min each)
with PBS+0.1% BSA, permeabilized/blocked with PBS+0.1%
BSA+10% GS+0.3% Triton 100 ×, during 1 h, at room
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bodies [1:200] nestin (NPC), [1:200] GFAP (astrocytes),
[1:500] β-III-tubulin (neurons) and [1:100] MAP2 followed
by 1 h incubation with [1:200] Alexa 488 and 568 secondary
antibodies. Nuclei were counterstained with 2 μg/mL Hoechst
diluted in PBS. Microphotographs were obtained by direct epi-
fluorescencemicroscope Olympus IX71 using the QCapture Pro
6.0 software and data analyzed with Adobe Image 7.0 soft-
ware. The number of cells positive to the different antibodies
was counted from a pool of at least 200 cells per photo, from 3
to 6 photos obtained from each condition, i.e. 600–1200 cells
were counted for one separate experiment. The respective
percentage of each cell type was then calculated.
Measurements of taurine concentration
Taurine levels were measured in tissue samples obtained
from adult mouse brain cortex and olfactory bulbs or in neu-
rospheres cultured in the presence or absence of taurine.
Samples were collected and washed with PBS, then resus-
pended in 150 μL of PBS and sonicated (30 s) with a Branson
Sonifier-250. For HPLC measurements, 10 μL of each sample
was mixed with 400 μL ethanol during 20 min, centrifugated
and filtered across 0.22 μm sterile membrane. 10 μL of the
filtered was derivatized with the same volume of
o-phthaldialdehyde and injected into a Beckman liquid chro-
matograph system. An ODS column (4.6×250 mm internal di-
ameter) was used, and the column effluent was monitored
with a fluorescence detector (emission at 460 nm and excita-
tion at 330 nm). The mobile phase was methanol/potassium
acetate (0.1 M, pH 5.5) and was run at a rate of 1.5 mL/min
in a linear gradient (15 min duration). Protein content was
determined by the Bradford procedure.
Taurine uptake experiments
Secondary neurospheres were disaggregated and plated on
poly-L-lysine-treated 48-well microplates (2×105 cells/
well) with culture media and incubated at 37 °C in humidi-
fied 5% CO2/95% air atmosphere during 24 h. For the uptake
assay, plates were washed with medium containing (in mM):
135 NaCl, 5 KCl, 1.7 KH2PO4, 1.17 MgSO4, 1 CaCl2, 5 glucose
and 10 HEPES; 300 mOsm, pH 7.4, and cells were incubated
30 min with 3H-taurine (0.8 μCi/ml; 29 nM) under the condi-
tion indicated for each assay. At the end of the experiment,
cells were washed and the accumulated radioactivity in cells
was measured in a liquid scintillation counter. Taurine uptake
is calculated as pmol/mg protein/min. KNO3 equimolarly
replaced NaCl to quantify the non-saturable component of
3H-taurine uptake. Osmolarity of all media was verified in a
freezing point osmometer from Precision Systems Inc. (Natick,
MA, USA).
Data analysis
All results are expressed as means±standard error (SE). A
t-test was used to detect significant differences at
*Pb0.05. Data in Fig. 3 were analyzed by one-way ANOVA
with Tukey's HSD post hoc test.
Supplementary materials related to this article can be
found online at doi:10.1016/j.scr.2012.02.004.Acknowledgments
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